Main container

Lanzoni Beatrice, MSc

CV

Date of Birth
15/12/1996
Qualification

Biologist

Current assignment

Biologist Fellow

Title of qualification awarded

2021: Master's Degree in Health Biology, Diagnostic-Forensic curriculum at Alma Mater Studiorum, University of Bologna 

Thesis in Pathological Anatomy: "Role of the inflammatory microenvironment in the first trimester of pregnancy in cases of recurrent pregnancy loss: immunohistochemical study"ue sarcomas.

Other qualifications awarded

2022: Qualification to the profession of Biologist2019: Bachelor's Degree in Biological Sciences at Alma Mater Studiorum, University of Bologna

Thesis in Molecular Pathology: "Cytological-molecular evaluation of residual material after needle washing during EBUS procedure in patients with lung cancer"

Positions held
  • January 2022- In progress: Fellowship at the Laboratory  of Experimental Oncology, IOR, Rizzoli Orthopedic Institute (Bologna)
  • Project: Molecular characterization of bone and soft tissue sarcomas, with the aim of defining alternative therapeutic pathways for patients who do not respond to conventional treatments.
  • March 2021 - December 2021: Execution of Covid-19 rapid antigenic swabs at "Farmacia di Zola", via Risorgimento 163/1, Zola Predosa (BO).
  • October 2020 - June 2021: Curricular internship in Pathological Anatomy at the USL of Bologna, Maggiore Hospital.
  • April 2018 - July 2018: Curricular internship in Molecular Oncological Pathology and Transplantation at the University Hospital of Bologna, Policlinico S. Orsola-Malpighi.
Languages
  • English: Fluent
  • Spanish: Basic

Technologies
  • Good knowledge and application skills of the Office package (Word; Excel; Power Point) and operating systems (Windows and Mac OS).
  • Molecular Biology: Extraction of nucleic acids from tumor and / or healthy histological pieces, cell pellets and FFPE sections; PCR; Real Time PCR; Gel Electrophoresis; Basic knowledge on NGS techniques for genetic sequencing
Clinical and/or Scientific interests

Identification of new therapeutic targets and validation of new treatment strategies, study of gene expression and molecular mechanisms mainly for patients with bone and soft tiss